Pharmacodynamics of insulin in polyethylene glycol-coated liposomes

International Journal of Pharmaceutics

Volumn 180, Issue 1, 1999, Pages 75-81

  Kim, Anna ^a   Yun, Mi Ok ^a   Oh, Yu Kyoung ^a   Ahn, Woong Shick ^b   Kim, Chong Kook ^a  

^a Seoul National University   (South Korea)

^b The Catholic University of Korea   (South Korea)

Author keywords

Incorporation; Insulin; Liposomes; Pharmacodynamics; Polyethylene glycol

Indexed keywords

DIMYRISTOYLPHOSPHATIDYLCHOLINE; DIPALMITOYLPHOSPHATIDYLCHOLINE; INSULIN; LIPOSOME; MACROGOL;

ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; GLUCOSE BLOOD LEVEL; INTRAVENOUS DRUG ADMINISTRATION; MALE; NONHUMAN; PARTICLE SIZE; PRIORITY JOURNAL; RAT; STREPTOZOCIN DIABETES;

ANIMALS; BLOOD GLUCOSE; DIABETES MELLITUS, EXPERIMENTAL; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; INSULIN; LIPOSOMES; MALE; PARTICLE SIZE; POLYETHYLENE GLYCOLS; RATS; RATS, SPRAGUE-DAWLEY;

EID: 0033062297     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-5173(98)00408-6     Document Type: Article

References (13)

1. Blume G., Cevc G. Liposomes for sustained drug release in vivo. Biochim. Biophys. Acta. 1029:1990;91-97.
2. Couvreur P., Fattal E., Andremont A. Liposomes and nanoparticles in the treatment of intracellular bacterial infections. Pharm. Res. 8:1991;1079-1086.
3. Debs R.J., Fuchs H.J., Philip R., Brunette E.N., Duzgunes N., Shellito J.E., Liggitt D., Patton J.R. Immunomodulatory and toxic effects of free and liposome-encapsulated tumor necrosis factor alpha in rats. Cancer Res. 50:1990;375-380.
4. Gabizon A.A., Barenholtz Y., Bialer M. Prolongation of the circulation time of doxorubicin encapsulated in liposome containing a polyethylene glycol-derivatized phospholipid: pharmacokinetic studies in rodents and dogs. Pharm. Res. 10:1993;703-708.
5. Gabizon A.A., Martin F.J. Polyethylene glycol-coated (pegylated) liposomal doxorubicin. Rationale for use in solid tumors. Drugs. 54(Suppl. 4):1997;15-21.
6. Kim C.-K., Han J.H. Lymphatic delivery and pharmacokinetics of methotrexate after intramuscular injection of differently charged liposome-entrapped methotrexate to rats. J. Microencapsulation. 12:1995;437-446.
7. Kim C.-K., Jeong E.J. Development of dried liposome as effective immuno-adjuvant for hepatitis B surface antigen. Int. J. Pharm. 115:1995;193-199.
8. Kim C.-K., Im E.B., Lim S.J., Oh Y.K., Han S.K. Development of glucose-triggered pH-sensitive liposomes for a potential insulin delivery. Int. J. Pharm. 101:1994;191-197.
9. Lasic D.D., Martin F.J., Gabizon A.A., Huang S.K., Papahadjopoulos D. Sterically stabilized liposomes: a hypothesis on the molecular origin of extended circulation times. Biochim. Biophys. Acta. 1070:1991;187-192.
10. Owens D.R. Human Insulin. Clinical Pharmacological Studies in Normal Man. 1986;98 MTP Press, Lancaster.
11. Sato H., Terasaki T., Okmura K., Tsuji A. Effect of receptor up-regulation on insulin pharmacokinetics in streptozotocin-treated rats. Pharm. Res. 8:1991;563-569.
12. Stewart J.C.M. Colorimetric determination of phospholipids with ammonium ferrothiocyanate. Anal. Biochem. 104:1959;10-14.
13. Woodle M.C., Storm G., Newman M.S., Jekot J.J., Collins L.R., Martin F.J., Szoka F.C. Jr. Prolonged systemic delivery of peptide drugs by long-circulating liposomes: illustration with vasopressin in the Brattleboro rat. Pharm. Res. 9:1992;260-265.